Brain Health

brain puzzle with piece missing and female symbol

Latest WAM Grant Recipients Take on Alzheimer’s Disease in Women Across Multiple Fronts

Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more

pathology image of a Lewy body inclusion
February 15, 2024/Neurosciences/Brain Health

Lewy Body Pathology Linked to Cerebral Amyloid Angiopathy in Alzheimer’s Disease Patients

Recognizing this association aids risk assessment before starting novel immunotherapies

image of astrocyte cell stained with antibodies to GFAP
February 14, 2024/Neurosciences/Brain Health

Longitudinal Study Links Biomarker Level With Repetitive Head Injury-Associated Neurodegeneration

GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline

23-NEU-4390509-CQD-Hero-650×450

Microglial Immunometabolism Endophenotypes Implicated in Sex Differences in Alzheimer’s Disease

Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-4357265-man-in-rural-setting-650×450
November 27, 2023/Neurosciences/Brain Health

Prospective Study Hints at Age-Related Memory Advantages for Rural Dwellers

For some older adults, a rural setting in late life may be protective

Dylan Wint, MD
August 22, 2023/Behavioral Health

The Difficult, Essential Talk About Dementia

Patients benefit when doctors disclose with care

23-NEU-4028232-CQD-Hero-2-650×450

Study Suggests New NINDS Criteria May Identify Fighters at Risk of Chronic Traumatic Encephalopathy

Criteria-based diagnosis of traumatic encephalopathy syndrome predicts changes in brain volumes and cognition

23-NEU-3890311_alzheimers-in-women_650x450

Pilot Study to Target Sex-Based Differences in Alzheimer’s Disease

Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women

23-NEU-3739358-CQD-Hero-650×450

Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s

High plasma ApoA1 and TG/HDL-C ratio predict faster progression

23-NEU-3600025-165292944-CQD-Hero-650×450
March 7, 2023/Geriatrics

New Cognitive Battery Reliably Screens for MCI, Early AD in Primary Care Setting

Self-administered tool can be completed in 10 minutes in waiting room

BackPage 1 of 3Next
Advertisement
Ad